The paracrine control of vascular motion. A historical perspective

Abstract

During the last quarter of the past century, the leading role the endocrine and nervous systems had on the regulation of vasomotion, shifted towards a more paracrine-based regulation. This begun with the recognition of endothelial cells as active players of vascular control, when the vessel's intimal layer was identified as the main source of prostacyclin and was followed by the discovery of an endothelium-derived smooth muscle cell relaxing factor (EDRF). The new position acquired by endothelial cells prompted the discovery of other endothelium-derived regulatory products: vasoconstrictors, generally known as EDCFs, endothelin, and other vasodilators with hyperpolarizing properties (EDHFs). While this research was taking place, a quest for the discovery of the nature of EDRF carried back to a research line commenced a decade earlier: the recently found intracellular messenger cGMP and nitrovasodilators. Both were smooth muscle relaxants and appeared to interact in a hormonal fashion. Prejudice against an unconventional gaseous molecule delayed the acceptance that EDRF was nitric oxide (NO). When this happened, a new era of research that exceeded the vascular field commenced. The discovery of the pathway for NO synthesis from L-arginine involved the clever assembling of numerous unrelated observations of different areas of knowledge. The last ten years of research on the paracrine regulation of the vascular wall has shifted to perivascular fat (PVAT), which is beginning to be regarded as the fourth layer of the vascular wall. Starting with the discovery of an adipose-derived relaxing substance (ADRF), the role that different adipokines have on the paracrine control of vasomotion is now filling the research activity of many vascular pharmacology labs, and surprising interactions between the endothelium, PVAT and smooth muscle are being unveiled.

Recent Pathophysiological Aspects of Peyronie’s Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment—Literature Review

“…In normal conditions, nitric oxide (NO) is the main mediator of penile erection and acts as a nonadrenergic and noncholinergic neurotransmitter, causing release of the smooth muscles of the corpora cavernosa. NO was also known as endothelium-derived relaxing factor (EDRF), and long-standing widespread prejudice held that EDRF could not be identified with unconventional gaseous molecule NO [45]. The chemical reaction producing NO occurs thanks to the presence of amino acid L-arginine via nitric oxide synthase (NOS) activity and leads to final synthesis of L-citrulline and NO (Table 1).…”

Endothelial Function in Children and Adolescents Is Mainly Influenced by Age, Sex and Physical Activity ― An Analysis of Reactive Hyperemic Peripheral Artery Tonometry ―

“…31 Endothelium-dependent dilation is influenced by various molecules. Nitric oxide (NO) is the major endotheliumderived relaxing factor; others are prostacyclin and endothelial-derived hyperpolarizing factor (EDHF).…”

“…35 In addition to the vessel's size and endothelial function, the vasoactive role of adventitial cells and perivascular adipose tissue is now a topic of research. 31 Different thickness of vessel layers in resistance and conduit vessels, interactions of various concentrations of vasoconstrictive and vasodilative molecules, and interactions between the endothelium, perivascular tissue and smooth muscle cells, may account for some failure of RHI-and FMD-correlation, as they may reflect different aspects of vascular damage. Although different methods are used to noninvasively assess endothelial function, they may not be interchangeable.…”

Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling

“…Endothelium-dependent vasodilation is regulated primarily by NO but also by prostacyclin (PGI 2 ) and an unidentified endothelium-derived hyperpolarizing factor. NO and PGI 2 are the predominant endogenous endothelial vaso-relaxant substances [20] . The NO-sGC-cGMP signaling cascade plays an essential role in vascular smooth muscle relaxation, and clinical studies indicate that endothelium-derived NO is involved in normal and pathological blood pressure regulation.…”